University of Oregon

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, University of Oregon sits in the top decile of US sponsors by registered trial count (#328 of 15,742 sponsors by registered trial count).

63 total trials 10 currently recruiting 47 completed early-phase tilt top decile by trial count

University of Oregon: 63 sponsored US clinical trials, 10 recruiting.

University of Oregon sponsors 63 registered US clinical trials on ClinicalTrials.gov, 10 of them currently recruiting, and 47 completed. 1 of these trials are in Phase 3-4 (later-stage) and 4 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Parent-Child Relations, with 5 trials.

Top-decile sponsor footprint

University of Oregon ranks in the top decile of sponsors by registered trial count (#328 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

A 90/100

47 of 47 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (100.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

63 total, page 2 of 2

COMPLETED NA

The Positive Family Support Project - Partnering With Families for a Successful Transition to School

NCT02289092
COMPLETED NA

Tailored Inhibitory Control Training to Reverse EA-linked Deficits in Mid-life

NCT02945371
COMPLETED NA

Safe, Healthy, Adolescent Relationships and Peers

NCT02420548
COMPLETED NA

Neurophysiology of Weakness and Exercise in Rotator Cuff Tendinopathy

NCT02971072
COMPLETED NA

Trial of KEEP-P, a Preventive Intervention for Foster Preschoolers (KEEP-P)

NCT03106636
COMPLETED NA

The Effects of Exercise Training on Shoulder Neuromuscular Control

NCT02164305
COMPLETED NA

Effects of Muscle Fatigue and Kinesio Taping on Shoulder Position Sense

NCT02104570
COMPLETED NA

Broader Implementation of a Successful Dual-Generation Intervention in Partnership With Head Start of Lane County

NCT02945384
COMPLETED NA

Chronic Heat Therapy for Improving Vascular Health

NCT02518399
COMPLETED NA

Muscle Regrowth During Physical Rehabilitation and Amino Acid Supplementation

NCT00760383
COMPLETED NA

Implementing School Wide PBS in Middle Schools: The Foundation for Effective Prevention

NCT04711681
COMPLETED NA

A Family Intervention for Adolescent Problem Behavior (AKA Project Alliance 2)

NCT01490307
COMPLETED NA

Early Family-Centered Prevention of Drug Use Risk (Aka Early Steps)

NCT01098695
← Previous Page 2 of 2

Phase Distribution

PhaseTrial count
Phase 1 3
Phase 2 1
Phase 4 1

Therapeutic Areas

Parent-Child Relations 5
Parenting 5
Depression 4
Parenting Self Efficacy 2
Child Behavior 2
Patent Foramen Ovale 2
Stress 2
Dementia 2
Intrapulmonary Arteriovenous Anastamosis 1
Proprioception 1

What is open in the University of Oregon pipeline

10 recruiting of 63 indexed (16% open); 47 completed (75%).

Phase mix: 1 late (III/IV) vs 4 early (I/II) (early-phase heavy).

Top condition: Parent-Child Relations (5 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

University of Oregon: open-pipeline peers nationwide

Peers matched on 63 registered trials and 16% open enrollment, not the therapeutic-area sidebar.

University of Oregon sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 05001,0001,5002,000 0%5%10%15%20% Total trials Recruiting share University of OregonActelionHennepin Healthcare Research InstituteUnited TherapeuticsCephalonUniversity of California, San FranciscoFox Chase Cancer CenterYoungstown State UniversityECOG-ACRIN Cancer Research Group
University of Oregon sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

University of Oregon sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 63 trials (± recruiting share)

Sponsors near 16% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this University of Oregon page

63 registered trials is a research-attention snapshot, not an endorsement of University of Oregon or any single study.

  • 10 of University of Oregon's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Parent-Child Relations is the condition University of Oregon studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Parent-Child Relations trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

University of Oregon pipeline card: 63 registered trials from official public datasets.Report a data error.